DrugInformations.org

University of Leicester experts have held discussions with military personnel in Afghanistan following the discovery of new technology to identify fingerprints on metal. Dr John Bond, a forensic research scientist at the University of Leicester and scientific support manager at Northamptonshire Police, has worked with a team from the University Department of Chemistry to develop the novel technique.

More: continued here

No Comments »

Emergent BioSolutions Inc. (NYSE:EBS) announced that it has received a contract from the Department of Health and Human Services (HHS) for over $24.3 million to fund the further development of Emergent’s anthrax monoclonal antibody AVP-21D9.

More: continued here

No Comments »

Dangerous disease often spreads faster than it takes to diagnose it in the lab. To remedy that, researchers at Kansas State University have developed a test to bring that time from days down to hours.

More: continued here

No Comments »

They have worked for almost seven years in secret. Most people did not know that the work in Ray Goehner’s materials characterization department at Sandia National Laboratories was contributing important information to the FBI’s investigation of letters containing bacillus anthracis, the spores that cause the disease anthrax. The spores were mailed in the fall of 2001 to several news media offices and to two U.S. senators. Five people were killed.

More: continued here

No Comments »

Fingerprints can reveal critical evidence, as well as an identity, with the use of a new technology developed at Purdue University that detects trace amounts of explosives, drugs or other materials left behind in the prints. The new technology also can distinguish between overlapping fingerprints left by different individuals - a difficult task for current optical forensic methods. A team led by R.

More: continued here

No Comments »

A new chemical probe can rapidly detect ricin, a deadly poison with no known antidote that is feared to be a potential weapon for terrorists and cannot quickly be identified with currently available tests. The probe, developed by chemists at UC San Diego, glows when bound to a ricin-damaged part of the body’s protein-making machinery, they report in the international edition of the journal Angewandte Chemie.

More: continued here

No Comments »

Emergent BioSolutions Inc. (NYSE:EBS) announced that it has submitted a proposal in response to a request for proposal (RFP) issued by the U.S. Department of Health and Human Services (HHS) for a recombinant protective antigen anthrax vaccine (rPA). Emergent’s rPA vaccine candidate is a reformulated and more stable form of the rPA 102 vaccine originally developed at the U.S.

More: continued here

No Comments »

Dr Bruce E Ivins, the 62-yar-old US biodefense scientist who was reportedly going to be charged with killing five people by mailing them letters containing finelly milled anthrax spores in 2001, was planning to kill his co-workers, a therapist told a Maryland court on 24th July, a week before Ivins committed suicide.

More: continued here

No Comments »

A University of Central Florida researcher may have found a defense against the Black Plague, a disease that wiped out a third of Europe’s population in the Middle Ages and which government agencies perceive as a terrorist threat today. UCF Professor Henry Daniell and his team have developed a vaccine that early research shows is highly effective against the plague.

More: continued here

No Comments »

Emergency room workers will be the first line of defense in the event of a disease pandemic and will be forced to deal with the chaos that inevitably comes with treating thousands of sick and dying. In order to protect themselves and allow them to care for the public, these first responders need to be fully prepared by getting available vaccines now.

More: continued here

No Comments »